FBI Approves Thermo Fisher Scientific's Rapid DNA Solution for use in Law Enforcement Booking Stations

FBI Approves Thermo Fisher Scientific’s Rapid DNA Solution for use in Law Enforcement Booking Stations Applied Biosystems RapidHIT ID DNA Booking System enables seamless integration of Rapid DNA into the law enforcement booking agency process SAN FRANCISCO, July 8, 2021 /PRNewswire/ — The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific’s Applied Biosystems... Read more

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 28, 2021

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 28, 2021 WALTHAM, Mass., July 7, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2021 before the market opens on Wednesday, July 28, 2021, and will hold... Read more

Expanded Gene Therapy Portfolio Supports More Efficient Adeno-Associated Viral Manufacturing

Expanded Gene Therapy Portfolio Supports More Efficient Adeno-Associated Viral Manufacturing New media panel, gene kit and advanced resins help reduce manufacturing costs while increasing the viability of gene therapies CARLSBAD, Calif., July 7, 2021 /PRNewswire/ — For gene therapy developers seeking to rapidly and efficiently scale production, a set of solutions is now available from Thermo... Read more

Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics

Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics Center will develop new technologies and reproducible analytical techniques to support rapid, cost-effective clinical research into applications for metabolomics in precision medicine SAN JOSE, Calif. and DAVIS, Calif., July 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, (NYSE: TMO) the world leader in serving... Read more

Thermo Fisher Scientific Announces Collaboration with Ortho Clinical Diagnostics

Exclusive agreement to provide Thermo Scientific MAS Quality Controls for VITROS Analyzers FREMONT, Calif., July 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Ortho Clinical Diagnostics to promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for use with Ortho Clinical Diagnostics VITROS... Read more

Thermo Fisher Scientific Launches Collection Kit to Streamline Saliva Testing

Self-collection kit facilitates raw saliva collection to aid global SARS-CoV-2 research and surveillance efforts CARLSBAD, Calif., June 29, 2021 /PRNewswire/ — As businesses, universities and schools reopen, SARS-CoV-2 virus surveillance is critical to the management of outbreaks and emerging new strains, including the Delta variant that now makes up 91 percent of new cases in... Read more

PerkinElmer Provides Update on Second Quarter Performance and Schedules Earnings Call for Wednesday, July 28, 2021

Company anticipates 2Q21 revenue and earnings to be above previously communicated guidance WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 24, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced ahead of this morning’s Virtual Investor and Analyst Day that it anticipates exceeding its previously announced financial guidance for the second quarter... Read more

Danaher Schedules Second Quarter 2021 Earnings Conference Call

WASHINGTON, June 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2021 on Thursday, July 22, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s... Read more

PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech

Solutions to complement Company’s growing position in cell and gene therapy research and development WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 22, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) is pleased to announce it has entered into an agreement to acquire SIRION Biotech GmbH, a leading, global provider of viral vector-based technologies that drive improved delivery performance for cell and gene... Read more